Investor Relations

Company Overview

Ekso Bionics® is a pioneer in the field of robotics. For over a decade we have been committed to developing the latest technology and engineering to commercialize wearable exoskeletons and robotic-assist devices in a variety of applications such as medical and industrial markets. Exoskeletons resolve unique customer challenges in rehabilitation allowing people to rethink their current physical limitations. Light-weight assist devices for industrial workers will help achieve mobility, strength, or endurance not otherwise possible. We remain committed to forming strategic partnerships for cutting-edge innovation. Ekso Bionics is headquartered in Northern California and listed under the symbol (NASDAQ: EKSO).

Learn more about Ekso Bionics here

2017 Shareholder Letter

EKSO featured on Fox Business’s “Morning with Maria”

View Video

CEO Tom Looby discusses the capabilities of EksoGT on CNBC’s “On the Money”

View Video

BuiltWorlds One takes an inside look at Ekso Bionics and the EksoVest

View Video

Ekso Bionics’ CEO Tom Looby presented at the Vodafone Industry Analyst Summit to discuss how Ekso Bionics leverages Vodafone technology to capture valuable data from our Ekso GT wearable exoskeletons.

View Video

A look into our first quarter at Ekso Bionics for 2017. Here is a peak on all we have accomplished this quarter.

View Video

C-Suite TV Interview with CFO Max Scheder-Bieschin Shares His Insightings on the Exoskeleton Industry

View Video

Fast Company Interview with CEO Tom Looby Explaining How EksoGT Can Help Paralyzed People Move

View Video

Bionic Suits Are Real And They're Transforming Everyday Life

View Video

Latest Financial Results

FY 2017

Fiscal Year Ended Dec 31, 2017

Stock Information


Ekso Bionics Holdings, Inc.



Day Range

52 week Range


Excellence through leadership

View Our Board

Contact Information

Investor Relations

Matthew Ventimiglia
T: 212-599-1265

Transfer Agent

VStock Transfer, LLC
77 Spruce Street
Suite 201
Cedarhurst, NY 11516
T: 212-828-8436